In H460 cells, down-regulation of CSTF2 resulted in an extension of the 3′ UTR of the shortened gene found in tumor tissues of NSCLC, suggesting that CSTF2 may be a therapeutic target for lung cancer (Aragaki et al., 2011). This evidence concerns the gene CSTF2 and non-small cell lung carcinoma.